AUS
NZ
UK
CA
USA
IND
Highlights
- Revenue down by 5.8% year-on-year.
- Net income decreased by 16% compared to the previous year.
- Profit margin recorded a decline to 15% from 17%.
The financial performance of Lycopodium (ASX:LYL) during the first half of 2025 has shown some notable shifts. The company's revenue has come in at AU$165.9 million, marking a reduction of 5.8% from the same period in 2024. Along with the decline in revenue, net income also experienced a decrease, falling 16% to AU$25.2 million.
The overall profit margin for Lycopodium dropped to 15% from a previous benchmark of 17% in the first half of 2024. This decline in margin is largely attributed to the reduced revenue streams. The earnings per share (EPS) similarly experienced a downward trend, now at AU$0.64 compared to AU$0.75 in the previous year.
Lycopodium's stock has witnessed a 7.8% decrease in the past week, reflecting the market's reaction to these financial results. From a risk perspective, the company's analysis indicates two warning signs that potential investors should consider in their evaluations.
Explore Market Opportunities
Our cutting-edge AI Stock Screener offers daily insights into various sectors, helping to uncover opportunities across:
- Dividend Powerhouses (3%+ Yield)
- Undervalued Small Caps with Insider Buying
- High growth Tech and AI Companies
Customize your search using over 50 metrics and explore for free.
For those seeking to share their feedback on this article or express concerns regarding the content, you are encouraged to reach out directly. Alternatively, email us at editorial-team (at) simplywallst.com.
This analysis by Simply Wall St is based on historical data and analyst predictions using an unbiased methodology. It is intended for general informational purposes and does not serve as financial advice. Furthermore, this piece does not assess your individual financial situation or objectives.
